MwanzoPSTV • NASDAQ
add
Plus Therapeutics Inc
$ 0.62
Baada ya Saa za Kazi:(1.54%)-0.0095
$ 0.61
Imefungwa: 24 Okt, 20:00:00 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 0.63
Bei za siku
$ 0.60 - $ 0.63
Bei za mwaka
$ 0.16 - $ 2.31
Thamani ya kampuni katika soko
61.03M USD
Wastani wa hisa zilizouzwa
33.33M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.39M | 8.68% |
Matumizi ya uendeshaji wa biashara | 1.68M | -23.65% |
Mapato halisi | 5.15M | 275.20% |
Kiwango cha faida halisi | 370.58 | 261.21% |
Mapato kwa kila hisa | -0.01 | 98.56% |
EBITDA | -1.46M | 58.58% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 6.88M | -18.45% |
Jumla ya mali | 10.35M | -7.69% |
Jumla ya dhima | 7.32M | -61.16% |
Jumla ya hisa | 3.03M | — |
hisa zilizosalia | 99.26M | — |
Uwiano wa bei na thamani | 21.16 | — |
Faida inayotokana na mali | -34.32% | — |
Faida inayotokana mtaji | 37.44% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 5.15M | 275.20% |
Pesa kutokana na shughuli | -5.80M | -404.17% |
Pesa kutokana na uwekezaji | -4.63M | -21.83% |
Pesa kutokana na ufadhili | 2.80M | -59.84% |
Mabadiliko halisi ya pesa taslimu | -7.63M | -479.61% |
Mtiririko huru wa pesa | -5.31M | -186.64% |
Kuhusu
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
Ilianzishwa
1996
Makao Makuu
Tovuti
Wafanyakazi
21
